{
    "annotations": [
        {
            "identifier": "T1",
            "position": [
                "344",
                "350"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Acesan"
        },
        {
            "identifier": "T2",
            "position": [
                "351",
                "371"
            ],
            "subtype": "Drug_dose",
            "type": "T",
            "value": "1 x 50 mg codziennie"
        },
        {
            "identifier": "T3",
            "position": [
                "419",
                "473"
            ],
            "subtype": "Investigation",
            "type": "T",
            "value": "kontrola saturacji przezsk\u00f3rnej i ci\u015bnienia t\u0119tniczego"
        },
        {
            "identifier": "T4",
            "position": [
                "602",
                "611"
            ],
            "subtype": "Investigation",
            "type": "T",
            "value": "Fibroskan"
        },
        {
            "identifier": "T5",
            "position": [
                "557",
                "599"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "ocen\u0105 w\u0105troby pod k\u0105tem objaw\u00f3w w\u0142\u00f3knienia"
        },
        {
            "identifier": "T6",
            "position": [
                "1678",
                "1684"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Acesan"
        },
        {
            "identifier": "T7",
            "position": [
                "1981",
                "1987"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Zyrtec"
        },
        {
            "identifier": "T8",
            "position": [
                "1990",
                "1999"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Flixonase"
        },
        {
            "identifier": "T9",
            "position": [
                "1918",
                "1924"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Acesan"
        },
        {
            "identifier": "T10",
            "position": [
                "1938",
                "1969"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "alergia   wziewna  i  pokarmowa"
        },
        {
            "identifier": "T11",
            "position": [
                "830",
                "889"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "Wrodzona wada serca pod postaci\u0105 dwunap\u0142ywowej lewej komory"
        },
        {
            "identifier": "T12",
            "position": [
                "892",
                "916"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "ubytkiem mi\u0119dzykomorowym"
        },
        {
            "identifier": "T13",
            "position": [
                "919",
                "936"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "malpozycj\u0105 naczy\u0144"
        },
        {},
        {
            "identifier": "T14",
            "position": [
                "939",
                "961"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "hipoplazj\u0105 \u0142uku aorty."
        },
        {
            "identifier": "T15",
            "position": [
                "973",
                "992"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "operacji m.Norwooda"
        },
        {
            "identifier": "T16",
            "position": [
                "993",
                "1003"
            ],
            "subtype": "Date",
            "type": "T",
            "value": "(09.08.11r"
        },
        {
            "identifier": "T17",
            "position": [
                "1017",
                "1050"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "operacji typu dwukierunkowy Glenn"
        },
        {
            "identifier": "T18",
            "position": [
                "1052",
                "1061"
            ],
            "subtype": "Date",
            "type": "T",
            "value": "02.03.12r"
        },
        {
            "identifier": "T19",
            "position": [
                "1066",
                "1085"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "Zw\u0119\u017cenie \u0142uku aorty"
        },
        {
            "identifier": "T20",
            "position": [
                "1099",
                "1135"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "implantacji stentu P-G do \u0142uku aorty"
        },
        {
            "identifier": "T21",
            "position": [
                "1138",
                "1146"
            ],
            "subtype": "Date",
            "type": "T",
            "value": "08.05.12"
        },
        {
            "identifier": "T22",
            "position": [
                "1152",
                "1185"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "P\u0119kni\u0119cie stentu z jego zw\u0119\u017ceniem"
        },
        {
            "identifier": "T23",
            "position": [
                "1199",
                "1238"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "angioplastyce balonowej zw\u0119\u017cenia stentu"
        },
        {
            "identifier": "T24",
            "position": [
                "1241",
                "1252"
            ],
            "subtype": "Date",
            "type": "T",
            "value": "21.01.14 r."
        },
        {
            "identifier": "T25",
            "position": [
                "1266",
                "1305"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "operacji metod\u0105 Fontana bez fenestracji"
        },
        {
            "identifier": "T26",
            "position": [
                "1324",
                "1353"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "Epizody bradykardii zatokowej"
        },
        {
            "identifier": "T27",
            "position": [
                "1371",
                "1413"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "Zw\u0119\u017cenie prawej t\u0119tnicy udowej zewn\u0119trznej"
        },
        {
            "identifier": "T28",
            "position": [
                "1416",
                "1444"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "W\u0105ska prawa t\u0119tnica biodrowa"
        },
        {
            "identifier": "T29",
            "position": [
                "1450",
                "1507"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "Podejrzenie niedro\u017cno\u015bci lewej \u017cy\u0142y biodrowej zewn\u0119trznej"
        },
        {
            "identifier": "T30",
            "position": [
                "1307",
                "1319"
            ],
            "subtype": "Date",
            "type": "T",
            "value": "21.01.2015r."
        },
        {
            "icd": "ICD10:Z91.0",
            "identifier": "N1",
            "referenced": "T10",
            "subtype": "Reference",
            "type": "N",
            "value": "Uczulenie na czynniki inne ni\u00c5\u00bc leki i substancje biologiczne w wywiadzie"
        },
        {
            "icd": "ICD10:Q20.4",
            "identifier": "N2",
            "referenced": "T11",
            "subtype": "Reference",
            "type": "N",
            "value": "Wej\u00c5\u009bcie obu dr\u00c3\u00b3g \u00c5\u00bcylnych do jedynej komory"
        },
        {
            "icd": "ICD10:Q21.0",
            "identifier": "N3",
            "referenced": "T12",
            "subtype": "Reference",
            "type": "N",
            "value": "Ubytek przegrody mi\u00c4\u0099dzykomorowej"
        },
        {
            "icd": "ICD10:Q20.3",
            "identifier": "N4",
            "referenced": "T13",
            "subtype": "Reference",
            "type": "N",
            "value": "Nieprawid\u00c5\u0082owe po\u00c5\u0082\u00c4\u0085czenia komorowo-t\u00c4\u0099tnicze"
        },
        {
            "icd": "ICD10:Q23.8",
            "identifier": "N5",
            "referenced": "T14",
            "subtype": "Reference",
            "type": "N",
            "value": "Inne wrodzone wady rozwojowe zastawki aortalnej i zastawki mitralnej"
        },
        {
            "icd": "ICD10:Z98.8",
            "identifier": "N6",
            "referenced": "T15",
            "subtype": "Reference",
            "type": "N",
            "value": "Inne okre\u00c5\u009blone stany po zabiegach chirurgicznych"
        },
        {
            "icd": "ICD10:Z98.8",
            "identifier": "N7",
            "referenced": "T17",
            "subtype": "Reference",
            "type": "N",
            "value": "Inne okre\u00c5\u009blone stany po zabiegach chirurgicznych"
        },
        {
            "icd": "ICD10:Q25.3",
            "identifier": "N8",
            "referenced": "T19",
            "subtype": "Reference",
            "type": "N",
            "value": "Zw\u00c4\u0099\u00c5\u00bcenie aorty"
        },
        {
            "icd": "ICD10:Z98.8",
            "identifier": "N9",
            "referenced": "T25",
            "subtype": "Reference",
            "type": "N",
            "value": "Inne okre\u00c5\u009blone stany po zabiegach chirurgicznych"
        },
        {
            "arg1": "T1",
            "arg2": "T2",
            "identifier": "R1",
            "subtype": "Drg",
            "type": "R"
        },
        {
            "arg1": "T21",
            "arg2": "T22",
            "identifier": "R10",
            "subtype": "Dat",
            "type": "R"
        },
        {
            "arg1": "T24",
            "arg2": "T25",
            "identifier": "R16",
            "subtype": "Dat",
            "type": "R"
        },
        {
            "arg1": "T30",
            "arg2": "T26",
            "identifier": "R17",
            "subtype": "Dat",
            "type": "R"
        },
        {
            "arg1": "T10",
            "arg2": "T9",
            "identifier": "R23",
            "subtype": "Alg",
            "type": "R"
        },
        {
            "arg1": "T16",
            "arg2": "T13",
            "identifier": "R4",
            "subtype": "Dat",
            "type": "R"
        },
        {
            "arg1": "T16",
            "arg2": "T14",
            "identifier": "R5",
            "subtype": "Dat",
            "type": "R"
        },
        {
            "arg1": "T16",
            "arg2": "T15",
            "identifier": "R6",
            "subtype": "Dat",
            "type": "R"
        },
        {
            "arg1": "T18",
            "arg2": "T19",
            "identifier": "R7",
            "subtype": "Dat",
            "type": "R"
        },
        {
            "arg1": "T18",
            "arg2": "T17",
            "identifier": "R8",
            "subtype": "Dat",
            "type": "R"
        }
    ],
    "originalText": "------------------------------------------------\nWiek: 8 lat\n------------------------------------------------\n------------------------------------------------\nP\u0142e\u0107: m\u0119ska\n------------------------------------------------\n------------------------------------------------\nZalecenia\n------------------------------------------------\nPrzyjmowanie:\n- Acesan 1 x 50 mg codziennie.\nKontrola kardiologiczna za 6-8 m-cy.\nOkresowa kontrola saturacji przezsk\u00f3rnej i ci\u015bnienia t\u0119tniczego.\nKonieczne obj\u0119cie ch\u0142opca opiek\u0105 w Poradni Hepatologicznej w miejscu zamieszkania ocen\u0105 w\u0105troby pod k\u0105tem objaw\u00f3w w\u0142\u00f3knienia.( Fibroskan)\n------------------------------------------------\nRozpoznanie lek. przyjm.\n------------------------------------------------\n Rozpozanie I: |Rozpoznanie II: |Rozpoznanie IV: |Rozpoznanie V: |Rozpoznanie III: |Opisowo:: Wrodzona wada serca pod postaci\u0105 dwunap\u0142ywowej lewej komory z ubytkiem mi\u0119dzykomorowym , malpozycj\u0105 naczy\u0144 i hipoplazj\u0105 \u0142uku aorty.\\x0aStan po operacji m.Norwooda (09.08.11r).\\x0aStan po operacji typu dwukierunkowy Glenn (02.03.12r)\\x0aZw\u0119\u017cenie \u0142uku aorty .\\x0aStan po implantacji stentu P-G do \u0142uku aorty ( 08.05.12 )\\x0aP\u0119kni\u0119cie stentu z jego zw\u0119\u017ceniem .\\x0aStan po angioplastyce balonowej zw\u0119\u017cenia stentu ( 21.01.14 r.).\\x0aStan po operacji metod\u0105 Fontana bez fenestracji (21.01.2015r.)\\x0aEpizody bradykardii zatokowej w wywiadzie .\\x0aZw\u0119\u017cenie prawej t\u0119tnicy udowej zewn\u0119trznej . W\u0105ska prawa t\u0119tnica biodrowa .\\x0aPodejrzenie niedro\u017cno\u015bci lewej \u017cy\u0142y biodrowej zewn\u0119trznej .\\x0a\\x0aQ20.2, Q21.0, Q20.3, I74.5 , Z98.8, R23.0\n------------------------------------------------\nZastosowane leczenie\n------------------------------------------------\nAcesan\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\nCh\u0142opiec  8  letni  w  stanie  dobrym   zosta\u0142 przyj\u0119ty  do  Kliniki celem przeprowadzenia  bada\u0144\nOtrzymuje  Acesan\nW wywiadzie  alergia   wziewna  i  pokarmowa Otrzymuje  Zyrtec+  Flixonase\n------------------------------------------------\nWyniki bada\u0144\n------------------------------------------------\nMorfologia krwi + PLT rozdzia\u0142 5 cz\u0119\u015b\u0107 WBC\n    WBC Krwinki bia\u0142e:9.98[10^3/ul]\n    RBC Krwinki czerwone:5.09[10^6/ul]\n    HGB Hemoglobina:13.6[g/dl]\n    HCT Hematokryt:39.8[%]\n    MCV wska\u017anik czerwonokrw:78.2[fl]\n    MCH wska\u017anik czerwonokrw:26.7[pg]\n    MCHC wska\u017anik czerwonokr:34.2[g/dl]\n    PLT z morfologii:191[10^3/ul]\n    RDW-SD:39.0[fl]\n    RDW-CV:13.8[%]\n    PDW:16.4[fl]\n    MPV:12.3[fl]\n    P-LCR:44.9[%]\n    PCT (hematokryt p\u0142ytkowy:0.23[%]\n    NEUTR# warto\u015b\u0107 bezwzgl\u0119d:7.90[10^3/ul]\n    NEUTR%:79.2[%]\n    LYMH# warto\u015b\u0107 bezwzgl\u0119dn:1.35[10^3/ul]\n    LYMPH%:13.5[%]\n    MONO# warto\u015b\u0107 bezwzgl\u0119dn:0.60[10^3/ul]\n    MONO%:6.0[%]\n    EO# warto\u015b\u0107 bezwzgl\u0119dna:0.07[10^3/ul]\n    EO%:0.7[%]\n    BASO# warto\u015b\u0107 bezwzgl\u0119dn:0.06[10^3/ul]\n    BASO%:0.6[%]\n    NRBC %:0.0[%]\n    NRBC #:0.00[10^3/ul]\nCzas kaolinowo-kefalinowy (APTT): APTT-SP:38.4[sek]\nCzas protrombinowy (PT)\n    Czas protrombinowy:14.0[sek]\n    Wska\u017anik PT:78.6[%]\n    INR:1.26\nCzas trombinowy TT: Czas trombinowy TT:15.0[sek]\nFibrynogen: Fibrynogen:2.34[g/L]\nP\u0142ytki krwi z THEX: P\u0142ytki krwi:194[10^3/ul]\nTSH: TSH:2.38[uIU/ml]\nFT3: FT3:4.40[pg/ml]\nFT4: FT4:1.49[ng/dl]\nWitamina D 25-OH: Witamina D 25-OH:13.8[ng/ml]\nAFP: AFP:1.94[IU/ml]\nALAT: ALAT:20[U/L]\nASPAT: ASPAT:39[U/L]\nBia\u0142ko ca\u0142kowite w surowicy (TP): Bia\u0142ko ca\u0142kowite w surow:7.3[g/dl]\nBilirubina ca\u0142kowita (TBil): Bilirubina ca\u0142kowita:0.75[mg/dl]\nCRP Bia\u0142ko C-reaktywne\n    CRP Bia\u0142ko C-reaktywne:\n    0.50[mg/dl]\nGammaglutamylotranspeptydaza (GGTP): Gammaglutamylotranspepty:38[U/L]\nKreatynina + GFR\n    Kreatynina w surowicy:0.45[mg/dl]\n    eGFR stand. wg Schwartza:160.1[ml/min/1,73 m^2]\n    eGFR zmod. wg Schwartza:120.2[ml/min/1,73 m^2]\n    wzrost:131[cm]\nMocznik: Mocznik:18[mg/dl]\nProfil parametr\u00f3w krytycznych (ABL)\n    pH:7.349\n    pCO2:43.4[mmHg]\n    BE:-1.90[mmol/L]\n    HCO3:23.3[mmol/L]\n    pO2:32.4[mmHg]\n    O2Sat:58.2[%]\n    S\u00f3d (ABL):138[mmol/L]\n    Potas (ABL):4.2[mmol/L]\n    Chlorki (ABL):113[mmol/L]\n    Wap\u0144 zjonizowany (ABL):1.23[mmol/L]\n    Ht - ABL:42.8[%]\n    Hb - ABL:13.9[g/dl]\n    FO2Hb:57.4[%]\n    FCOHb:0.6[%]\n    FMetHb:0.7[%]\n    Glukoza (ABL):85[mg/dl]\n    Mleczany:16[mg/dl]\n------------------------------------------------\nICD10\n------------------------------------------------\nQ20.3\nZ98.8\nQ21.0\nR23.0\nQ20.2\n------------------------------------------------\n------------------------------------------------\nICD9\n------------------------------------------------\n89.522\nC66\nI81\n87.415\nG21\nI89\nG25\nL69\nL07\nO69\n88.716\nC55\nG53\nO91\nG11\nI77\nL31\nI17\nO55\nI19\nM37\nN13\n88.721\n8\n88.761\n------------------------------------------------"
}